妊娠期钆螯合物安全性:宫内暴露后幼年非人灵长类动物体内钆水平几乎检测不到
本研究对10只妊娠恒河猴在妊娠第85天和第135天静脉注射钆特醇后行胎盘MRI,子代出生后随访7个月,用ICP-MS检测8种组织及血液的钆水平。羊水中可检测到钆,证实其可穿过胎盘;幼猴股骨和肝脏中钆水平极低,其余组织大多检测不到,仅个别皮肤、脾、脑和肾样本可检出。
要点
- 羊水中钆浓度0.028×10-5 %ID/g(给药后50天),证实钆特醇可穿过胎盘。
- 幼猴股骨钆均值2.5×10-5 %ID/g(范围0.81-4.1×10-5 %ID/g),肝脏均值0.15×10-5 %ID/g(范围0-0.26×10-5 %ID/g)。
- 其余采样组织大多检测不到钆,仅个别皮肤、脾、脑和肾样本可检出。
核心结论
- 母体注射钆特醇后羊水中存在钆,证实其可穿过胎盘;宫内暴露于两剂钆特醇后幼猴组织中钆水平极低,提示极少量钆在分娩后持续存在。
研究设计与样本
- 前瞻性动物研究,妊娠恒河猴及其子代共10只,经机构动物护理与利用委员会批准,作为评估母体营养不良对胎盘和胎儿发育影响的现有研究方案的一部分;于妊娠第85天和第135天静脉注射钆特醇后行胎盘MRI,第135天第二次给药前行羊膜穿刺;分娩后子代随访7个月,取8种不同器官及血液样本,用 inductively coupled plasma mass spectrometry 检测钆水平。
诊断标准与关键数值
- 羊水钆浓度0.028×10-5 %ID/g(单剂钆特醇给药后50天)。
- 股骨钆均值2.5×10-5 %ID/g(范围0.81-4.1×10-5 %ID/g)。
- 肝脏钆均值0.15×10-5 %ID/g(范围0-0.26×10-5 %ID/g)。
- 其余采样组织检测不到,例外为1份皮肤样本0.07×10-5 %ID/g、1份脾样本0.039×10-5 %ID/g、1份脑样本0.095×10-5 %ID/g和1份肾样本0.13×10-5 %ID/g。
临床应用与阅片要点
- 作者结论认为,宫内暴露于两剂钆特醇后幼猴组织中钆水平极低,提示极少量钆在分娩后持续存在。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To determine whether gadolinium remains in juvenile nonhuman primate tissue after maternal exposure to intravenous gadoteridol during pregnancy. Materials and Methods Gravid rhesus macaques and their offspring (n = 10) were maintained, as approved by the institutional animal care and utilization committee. They were prospectively studied as part of a pre-existing ongoing research protocol to evaluate the effects of maternal malnutrition on placental and fetal development. On gestational days 85 and 135, they underwent placental magnetic resonance imaging after intravenous gadoteridol administration. Amniocentesis was performed on day 135 prior to administration of the second dose of gadoteridol. After delivery, the offspring were followed for 7 months. Tissue samples from eight different organs and from blood were harvested from each juvenile macaque. Gadolinium levels were measured by using inductively coupled plasma mass spectrometry. Results Gadolinium concentration in the amniotic fluid was 0.028 × 10-5 %ID/g (percentage injected dose per gram of tissue) 50 days after administration of one gadoteridol dose. Gadolinium was most consistently detected in the femur (mean, 2.5 × 10-5 %ID/g; range, [0.81-4.1] × 10-5 %ID/g) and liver (mean, 0.15 × 10-5 %ID/g; range, [0-0.26] × 10-5 %ID/g). Levels were undetectable in the remaining sampled tissues, with the exception of one juvenile skin sample (0.07 × 10-5 %ID/g), one juvenile spleen sample (0.039 × 10-5 %ID/g), and one juvenile brain (0.095 × 10-5 %ID/g) and kidney (0.13 × 10-5 %ID/g) sample. Conclusion The presence of gadoteridol in the amniotic fluid after maternal injection enables confirmation that it crosses the placenta. Extremely low levels of gadolinium are found in juvenile macaque tissues after in utero exposure to two doses of gadoteridol, indicating that a very small amount of gadolinium persists after delivery. © RSNA, 2017.
引用
- Prola-Netto J, Woods M, Roberts VHJ, et al. Gadolinium Chelate Safety in Pregnancy: Barely Detectable Gadolinium Levels in the Juvenile Nonhuman Primate after in Utero Exposure. Radiology. 2017. PMID: 28873045. doi:10.1148/radiol.2017162534
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。